Trials / Recruiting
RecruitingNCT06566352
Different Methods to Minimize Blood Loss During Laparoscopic Myomectomy; A Randomized Controlled Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Zagazig University · Other Government
- Sex
- Female
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
Laparoscopic myomectomy with temporary bilateral uterine artery occlusion or intramyometrial injection of diluted epinephrine will be important to reduce intraoperative bleeding, time of operation and hospitalization period after laparoscopic myomectomy.
Detailed description
Laparoscopic myomectomy with temporary bilateral uterine artery occlusion or intramyometrial injection of diluted epinephrine will be important to reduce intraoperative bleeding, time of operation, and hospitalization period after laparoscopic myomectomy. This will be the first study to investigate the efficacy of Laparoscopic myomectomy with temporary bilateral uterine artery occlusion or intramyometrial injection of diluted epinephrine in minimizing blood loss during Laparoscopic myomectomy at our university. Can Laparoscopic myomectomy with temporary bilateral uterine artery occlusion or intramyometrial injection of diluted epinephrine give better outcomes regarding intraoperative bleeding when compared to traditional laparoscopic myomectomy?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laparoscopic myomectomy with intramyometrial injection of diluted epinephrine | intramyometrial injection of epinephrine 1mg diluted in 200mg of NaCl solution |
| PROCEDURE | traditional laparoscopic myomectomy | traditional laparoscopic myomectomy |
| PROCEDURE | laparoscopic myomectomy with temporary bilateral uterine artery occlusion | Experimental: laparoscopic myomectomy with temporary bilateral uterine artery occlusion |
| DRUG | injection of epinephrine 1mg diluted in 200mg of NaCl | injection of epinephrine 1mg diluted in 200mg of NaCl |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2025-05-01
- Completion
- 2025-05-01
- First posted
- 2024-08-22
- Last updated
- 2024-08-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06566352. Inclusion in this directory is not an endorsement.